NDC00378-7503-32: BUDESONIDE INHALATION SUSPENSION.
BUDESONIDE INHALATION SUSPENSION. Key specifications include part_name_assigned_by_controlling_agency: BREYNA 160-4.5MCG INH 120 (BUDESONIDE/FORMOTEROL HFA 160-4.5MCG). This part is cataloged in the U.S.
Government catalog under NSN 6505-01-717-0530, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | BREYNA 160-4.5MCG INH 120 (BUDESONIDE/FORMOTEROL HFA 160-4.5MCG) |
| NSN | 6505-01-717-0530 |
| SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF ASTHMA IN PATIENTS 6 YEARS OF AGE AND OLDER; GENERIC SYMBICORT TO CONTROL AND PREVENT SYMPTOMS CAUSED BY ASTHMA AND LUNG DISEASE. BUDESONIDE IS A CORTICOSTEROID THAT REDUCES INFLAMMATION AND SWELLING OF THE AIRWAYS AND FORMOTEROL IS A LONG-ACTING BETA AGONIST THAT RELAXES MUSCLES AROUND THE AIRWAY. INHALER MUST BE PRIMED BEFORE USE OR AFTER GOING UNUSED FOR 7 OR MORE DAYS. STORE AT CONTROLLED ROOM TEMPERATURE (68-77 DEGREES F) AND DISCARD INHALER 3 MONTHS AFTER YOU REMOVE IT FROM ORIGINAL FOIL PACKAGING. HAZMAT PRODUCT; FOR ORAL INHALATION ONLY; CONTENTS: EACH CARTON CONTAINS ONE CANISTER. NET FILL WEIGHT 10.3 G. PROVIDING 120 INHALATIONS. G |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BREYNA 160-4.5MCG INH 120 (BUDESONIDE/FORMOTEROL HFA 160-4.5MCG) |